Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacqueline Glascock

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Human Gene Therapy|September 1, 2010
Combination of SMN trans-splicing and a neurotrophic factor increases the life span and body mass in a severe model of spinal muscular atrophyMonir Shababi, Jacqueline Glascock, Christian L Lorson
Contemporary Clinical Trials Communications|February 9, 2026
An updated review of the SMA clinical trial landscape in the United States: Findings from analysis of recruitment targets on ClinicalTrials.gov and a survey of SMA clinical trial sites on factors affecting site capacity and readinessFatou Sarr, Ilse Peterson, Jacqueline Glascock, et al.
Orphanet Journal of Rare Diseases|October 17, 2025
A qualitative, mixed-method approach to reaching consensus on function, fatigue, and fatigability outcomes in teens and adults living with spinal muscular atrophyJacqueline Glascock, Lisa T Belter, Meghan Moore Burk, et al.
JAMA Pediatrics|July 15, 2024
Newborn Screening and Birth Prevalence for Spinal Muscular Atrophy in the USLisa Belter, Jennifer L Taylor, Erica Jorgensen, et al.
Journal of Neuromuscular Diseases|July 17, 2023
Identifying Biomarkers of Spinal Muscular Atrophy for Further DevelopmentJacqueline Glascock, Basil T Darras, Thomas O Crawford, et al.
Journal of Neuromuscular Diseases|April 5, 2018
Treatment Algorithm for Infants Diagnosed with Spinal Muscular Atrophy through Newborn ScreeningJacqueline Glascock, Jacinda Sampson, Amanda Haidet-Phillips, et al.
Journal of Neuromuscular Diseases|February 3, 2020
Revised Recommendations for the Treatment of Infants Diagnosed with Spinal Muscular Atrophy Via Newborn Screening Who Have 4 Copies of SMN2Jacqueline Glascock, Jacinda Sampson, Anne M Connolly, et al.
Immunohorizons|July 24, 2018
The RNA-Binding Protein HuR Posttranscriptionally Regulates IL-2 Homeostasis and CD4<sup>+</sup> Th2 DifferentiationPatsharaporn Techasintana, Jason S Ellis, Jacqueline Glascock, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Human Gene Therapy|September 1, 2010
Combination of SMN trans-splicing and a neurotrophic factor increases the life span and body mass in a severe model of spinal muscular atrophyMonir Shababi, Jacqueline Glascock, Christian L Lorson
Contemporary Clinical Trials Communications|February 9, 2026
An updated review of the SMA clinical trial landscape in the United States: Findings from analysis of recruitment targets on ClinicalTrials.gov and a survey of SMA clinical trial sites on factors affecting site capacity and readinessFatou Sarr, Ilse Peterson, Jacqueline Glascock, et al.
Orphanet Journal of Rare Diseases|October 17, 2025
A qualitative, mixed-method approach to reaching consensus on function, fatigue, and fatigability outcomes in teens and adults living with spinal muscular atrophyJacqueline Glascock, Lisa T Belter, Meghan Moore Burk, et al.
JAMA Pediatrics|July 15, 2024
Newborn Screening and Birth Prevalence for Spinal Muscular Atrophy in the USLisa Belter, Jennifer L Taylor, Erica Jorgensen, et al.
Journal of Neuromuscular Diseases|July 17, 2023
Identifying Biomarkers of Spinal Muscular Atrophy for Further DevelopmentJacqueline Glascock, Basil T Darras, Thomas O Crawford, et al.
Journal of Neuromuscular Diseases|April 5, 2018
Treatment Algorithm for Infants Diagnosed with Spinal Muscular Atrophy through Newborn ScreeningJacqueline Glascock, Jacinda Sampson, Amanda Haidet-Phillips, et al.
Journal of Neuromuscular Diseases|February 3, 2020
Revised Recommendations for the Treatment of Infants Diagnosed with Spinal Muscular Atrophy Via Newborn Screening Who Have 4 Copies of SMN2Jacqueline Glascock, Jacinda Sampson, Anne M Connolly, et al.
Immunohorizons|July 24, 2018
The RNA-Binding Protein HuR Posttranscriptionally Regulates IL-2 Homeostasis and CD4<sup>+</sup> Th2 DifferentiationPatsharaporn Techasintana, Jason S Ellis, Jacqueline Glascock, et al.
Pageof 1